共 125 条
[1]
Babjuk M(2017)EAU guidelines on non-muscle-invasive Urothelial carcinoma of the bladder: update 2016 Eur Urol 71 447-461
[2]
Bohle A(2016)Cancer treatment and survivorship statistics, 2016 CA Cancer J Clin 66 271-289
[3]
Burger M(2001)Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients J Clin Oncol 19 666-675
[4]
Capoun O(2005)Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer J Clin Oncol 23 4602-4608
[5]
Cohen D(2006)Radical cystectomy for invasive bladder cancer: long-term results of a standard procedure World J Urol 24 296-304
[6]
Comperat EM(2001)Cystectomy for bladder cancer: a contemporary series J Urol 165 1111-1116
[7]
Miller KD(1999)Prognostic factors of outcome after radical cystectomy for bladder cancer: a retrospective study of a homogeneous patient cohort J Urol 161 1494-1497
[8]
Siegel RL(1997)el-Mekresh MM, el-Baz MA, el-attar IA, Ashamallah a. radical cystectomy for carcinoma of the bladder: critical evaluation of the results in 1,026 cases J Urol 158 393-399
[9]
Lin CC(2009)Potential impact of postoperative early complications on the timing of adjuvant chemotherapy in patients undergoing radical cystectomy: a high-volume tertiary cancer center experience Eur Urol 55 177-185
[10]
Mariotto AB(2014)Eligibility for neoadjuvant/adjuvant cisplatin-based chemotherapy among radical cystectomy patients BJU Int 113 E17-E21